Evaxion will slightly delay the filing and publication of its 2025 annual report, planned before opening of Nasdaq CM today, due to unforeseen technical issues with external vendors. The report has been finalized as planned and will be filed and published as soon as possible. The technical issues relate to regulatory filing demands and have nothing to do with the report itself. As a consequence of the technical delay, the conference call and webcast planned for today will be moved to tomorrow: Friday March 6 at 8.30 ET/14.30 CET.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVAX:
- Is EVAX a Buy, Before Earnings?
- Evaxion Sets March 5 Date for 2025 Results and Business Update
- Evaxion Biotech Issues Over 9 Million New Warrants to Insiders in February 2026
- Evaxion Biotech initiated with a Buy at Maxim
- Evaxion Extends AI-Immunology Platform to Autoimmune Diseases and Sets 2026 Milestones